Intrinsic Value

Rubius Therapeutics, Inc. (RUBY)

$0.057

+0.00 (+2.70%)

Enterprise Value -
Net Debt -13.77
Equity Value -
Shares Outstanding 90.31
Equity Value Per Share -



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt